The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 02, 2019
Filed:
Dec. 10, 2015
Applicant:
Actelion Pharmaceuticals Ltd, Allschwil, CH;
Inventors:
Martine Clozel, Allschwil, CH;
Luca Piali, Basel, CH;
Assignee:
ACTELION PHARMACEUTICALS LTD, Allschwil, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/426 (2006.01); A61K 31/22 (2006.01); A61K 31/225 (2006.01); A61K 31/4015 (2006.01); A61K 31/27 (2006.01);
U.S. Cl.
CPC ...
A61K 31/426 (2013.01); A61K 31/22 (2013.01); A61K 31/225 (2013.01); A61K 31/27 (2013.01); A61K 31/4015 (2013.01);
Abstract
The present invention relates to a pharmaceutical combination comprising a first active ingredient which is (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[Z]ylidene]-2-([Z]propylimino)-3-o-tolyl-thiazolidin-4-one or a pharmaceutically acceptable salt thereof and a second active ingredient which is selected from the group consisting of methyl fumarate, dimethyl fumarate, (N,N-diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, and 2-(2,5-dioxopyrrolidin-1-yl)ethyl methyl (2E)but-2-ene-1,4-dioate, or a pharmaceutically acceptable salt thereof.